Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Niho

Showing results (11-20 of 571) with videos related to

Pageof 58
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 10, 1994
[Optimal administration of 5-FU and cisplatin based on biochemical modulation in the treatment of non-resectable non-small cell lung carcinoma]S Nakano, Y Niho
Ryoikibetsu Shokogun Shirizu|December 2, 1998
[Myeloperoxidase deficiency]T Okamura, Y Niho
Ryoikibetsu Shokogun Shirizu|December 2, 1998
[Jordans' anomaly]Y Asano, Y Niho
Internal Medicine (Tokyo, Japan)|May 25, 1999
Cytophagic histiocytic panniculitis--what is the best therapy?T Okamura, Y Niho
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1978
Culture of granulopoietic progenitor cellsY Niho, N Kimura
Ryoikibetsu Shokogun Shirizu|December 2, 1998
[Job's syndrome]Y Asano, Y Niho
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|July 1, 1985
Demonstration of eosinophil colony-stimulating activity in Sézary cell-conditioned mediumT Shibuya, Y Niho
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1985
Hepatitis BT Otsuka, Y Niho
Current Opinion in Hematology|July 17, 1998
Fas/Fas ligand and hematopoietic progenitor cellsY Niho, Y Asano
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 15, 2000
[Interleukin-3 (IL-3), IL-4, IL-5]Y Asano, Y Niho
Pageof 58

Showing results (11-20 of 571) with videos related to

Sort By:
Pageof 58
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 10, 1994
[Optimal administration of 5-FU and cisplatin based on biochemical modulation in the treatment of non-resectable non-small cell lung carcinoma]S Nakano, Y Niho
Ryoikibetsu Shokogun Shirizu|December 2, 1998
[Myeloperoxidase deficiency]T Okamura, Y Niho
Ryoikibetsu Shokogun Shirizu|December 2, 1998
[Jordans' anomaly]Y Asano, Y Niho
Internal Medicine (Tokyo, Japan)|May 25, 1999
Cytophagic histiocytic panniculitis--what is the best therapy?T Okamura, Y Niho
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1978
Culture of granulopoietic progenitor cellsY Niho, N Kimura
Ryoikibetsu Shokogun Shirizu|December 2, 1998
[Job's syndrome]Y Asano, Y Niho
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|July 1, 1985
Demonstration of eosinophil colony-stimulating activity in Sézary cell-conditioned mediumT Shibuya, Y Niho
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1985
Hepatitis BT Otsuka, Y Niho
Current Opinion in Hematology|July 17, 1998
Fas/Fas ligand and hematopoietic progenitor cellsY Niho, Y Asano
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 15, 2000
[Interleukin-3 (IL-3), IL-4, IL-5]Y Asano, Y Niho
Pageof 58